TEWKSBURY, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today announced that a case study recently featured in Diagnostic and Interventional Cardiology (DAIC) as the Case of the Week highlights Cambridge Heart’s Microvolt T-Wave Alternans™ (MTWA) test.
